Intersecting HIV and mpox epidemics: more questions than answers
Girometti N., Ogoina D., Tan D.H.S., Pozniak A., Klein M.B., Journal of the International AIDS Society, 2022
Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Klein MB, Young J, Ortiz-Paredes D, Wang S, Walmsley S, Wong A, Martel-Laferrière V, Pick N, Conway B, Angel J, Baril JG, Fraser C, Lebouché B, Tan DHS, Sandre R, Trottier S, Peiris H, Jayaraman J, Singer J; CTN 286 Study Investigators., Patient Prefer Adherence, 2022
Sleep as a Mediator Between Cannabis Use and Psychosis Vulnerability: A Longitudinal Cohort Study
Ouellet J., Spinney S., Assaf R., Boers E., Livet A., Potvin S., Conrod P.J., Schizophrenia Bulletin Open, 2022
Using synthetic controls to estimate the population-level effects of Ontario’s recently implemented overdose prevention sites and consumption and treatment services
Dimitra Panagiotoglou, Jihoon Lim, International Journal of Drug Policy, 2022
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study
Zolopa C., Brothers T.D., Leclerc P., Mary J.F., Morissette C., Bruneau J., Hyshka E., Martin N.K., Larney S., International Journal of Drug Policy, 2022
Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: a scoping review
Kaur N, Bastien G, Gagnon L, Graham J, Mongeau-Pérusse V, Bakouni H, Morissette F, Theriault C, Fischer B, Jutras-Aswad D., Frontiers in Psychiatry, 2022
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial
Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Addiction. 2022
What are the best practices for psychotherapy with Indigenous peoples in the United States and Canada? A thorny question
Wendt D.C., Huson K., Albatnuni M., Gone J.P., Journal of Consulting and Clinical Psychology, 2022
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions
Garel N, McAnulty C, Greenway KT, Lesperance P, Miron JP, Rej S, Richard-Devantoy S, Jutras-Aswad D., Drug and Alcohol Dependence, 2022
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial
McAnulty C, Bastien G, Eugenia Socias M, Bruneau J, Le Foll B, Lim R, Brissette S, Ledjiar O, Marsan S, Talbot A, Jutras-Aswad D; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse., Drug Alcohol Depend. 2022
